• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Youngevity International, Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation, Financial Statements and Exhibits

    5/2/22 4:15:35 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services
    Get the next $YGYI alert in real time by email
    8-K 1 yii20220429_8k.htm FORM 8-K yii20220429_8k.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (date of earliest event reported): February 18, 2022

     

    YOUNGEVITY INTERNATIONAL, INC.

    (Exact name of registrant as specified in its charter)

     

    Delaware

     

    001-38116

     

    90-0890517

    (State or other jurisdiction of incorporation)

     

    (Commission File No.)

     

    (IRS Employer Identification No.)

     

    2400 Boswell Road, Chula Vista, CA 91914

    (Address of principal executive offices) (Zip Code)

     

     

    Registrant’s telephone number, including area code: (619) 934-3980

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

    Trading Symbol(s)

    Name of each exchange on which registered

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by checkmark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

     

     



     

     

     

     

    Item 2.04. Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.

     

    On February 18, 2022, Crestmark Bank (“Crestmark”) issued to Youngevity International, Inc. (the “Company”) a notice regarding certain Defaults, as defined in the Amended and Restated Loan and Security Agreement dated November 16, 2017, by and between Crestmark, CLR Roasters, LLC (“Borrower”) and the Company, Stephan R. Wallach and David Briskie, as Guarantor (the “Guarantors”), as amended (the "Loan Agreement'), existing under the Loan Agreement and Loan Documents (as defined in the Loan Agreement). The Loan Documents include a Second Amended and Restated Promissory Note issued to Crestmark Bank on January 19, 2022, in the principal amount of $3,000,000 (the “Second Amended and Restated Promissory Note”). The Defaults were stated to include, but not be limited to, Borrower's failure to provide the quarter1y Management Prepared Financial Statements for the quarters ended September 30, 2021, and December 31, 2021, as set forth in Section 13 of the Schedule to the Loan Agreement. As a result of these Defaults, Crestmark has the right to charge the Extra Rate defined in, the Loan Documents, and had the right to accelerate the indebtedness, and to enforce any other right or remedy set forth in the Loan Documents and under applicable law.

     

    On April 4, 2022, the Company, Borrower and the Guarantors entered into a Forbearance Agreement with Crestmark (the “Forbearance Agreement”) pursuant to which Crestmark agreed to forbear from collection action under the Loan Documents until the earlier of June 30, 2022, or the occurrence of a new Default.

     

    A copy of the Loan Agreement, as amended, the Second Amended and Restated Promissory Note and the Forbearance Agreement are attached as Exhibits 10.1, 10.2, 10.3, 10.4 and 10.5 to this Current Report on Form 8-K and are incorporated herein by reference.

     

    Item 9.01. Financial Statements and Exhibits.

     

     

    (d)

    Exhibits.

     

    Exhibit Number

      Description
         

    10.1

     

    Loan and Security Agreement with Crestmark Bank and related schedules dated November 16, 2017 (incorporated herein by reference to Exhibit 10.43 to the Company’s Annual Report on Form 10-K, File No. 000-54900, filed with the Securities and Exchange Commission on March 30, 2018)

    10.2

     

    Amendment No. 1 to the Loan and Security Agreement with Crestmark Bank, dated December 29, 2017 (incorporated herein by reference to Exhibit 10.44 to the Company’s Annual Report on Form 10-K, File No. 000-54900, filed with the Securities and Exchange Commission on March 30, 2018)

    10.3

     

    Amendment No.2 to the Loan and Security Agreement with Crestmark Bank, dated January 19, 2022

    10.4

     

    Second Amended and Restated Promissory Note issued to Crestmark Bank, dated January 19, 2022

    10.5

     

    Forbearance Agreement with Crestmark Bank, dated April 4, 2022

     

     

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

    YOUNGEVITY INTERNATIONAL, INC.

       

    Date: May 2, 2022

    By: /s/ David Briskie

     

    Name: David Briskie

     

    Title: President and Chief Investment Officer

     

     

     

     

     

     
    Get the next $YGYI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $YGYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $YGYI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Youngevity International, Inc Granted Motion for Summary Judgement Against Former President Dwayne Dundore

    Florida Court Issues Order Awarding Youngevity Damages of $20,915,507 SAN DIEGO, Sept. 21, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTCMRKTS: YGYI) ("Youngevity") and its subsidiary Khrysos Industries, Inc today announced that the Circuit Court of the Ninth Judicial Circuit in and for Orange County, Florida, has issued an order against former Khrysos President Dwayne Dundore granting Youngevity's Motion for Summary Judgement on Counts III (Fraudulent Inducement) and IV (Breach Of Employment Agreement), awarding Youngevity $20,915,507 in damages.  A complete copy of

    9/21/22 8:30:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Provides Update on Financial Reporting and Files Forms 10-Q for Quarters Ended March 31, June 30, and September 30, 2020

    SAN DIEGO, June 22, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise, a direct marketing enterprise, and a nutraceutical manufacturing enterprise, today reported financial results for the quarters ended March 31, June 30, and September 30, 2020. Steve Wallach, Chairman and CEO of Youngevity International stated, "We are making progress toward reaching fully reporting status with the filing of our 10-Qs for the first

    6/22/22 9:22:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for May 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, May 20, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for May 2022.  The dividend will be payable on June 15, 2022, to holders of record as of May 31, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity International, Inc. is a multi-channel lifestyle company operating in three distinct business segments including a com

    5/20/22 8:30:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    $YGYI
    SEC Filings

    View All

    SEC Form REVOKED filed by Youngevity International, Inc.

    REVOKED - Youngevity International, Inc. (0001569329) (Filer)

    12/6/23 10:32:42 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Youngevity International, Inc. (0001569329) (Filer)

    7/11/22 5:15:23 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    SEC Form 10-Q filed by Youngevity International, Inc.

    10-Q - Youngevity International, Inc. (0001569329) (Filer)

    6/22/22 8:52:54 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    $YGYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Youngevity International, Inc.

    SC 13G - Youngevity International, Inc. (0001569329) (Subject)

    5/6/22 3:48:41 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    SEC Form SC 13G filed

    SC 13G - Youngevity International, Inc. (0001569329) (Subject)

    3/11/21 2:31:16 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    $YGYI
    Financials

    Live finance-specific insights

    View All

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for May 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, May 20, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for May 2022.  The dividend will be payable on June 15, 2022, to holders of record as of May 31, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity International, Inc. is a multi-channel lifestyle company operating in three distinct business segments including a com

    5/20/22 8:30:00 AM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for April 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, April 19, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTCM: YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for April 2022.  The dividend will be payable on May 16, 2022, to holders of record as of April 29, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity International, Inc. is a multi-channel lifestyle company operating in three distinct business segments includin

    4/19/22 5:04:00 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services

    Youngevity International, Inc. Announces Declaration of Monthly Dividend for the 1st Quarter 2022 for Series "D" Cumulative Redeemable Perpetual Preferred Stock

    SAN DIEGO, Jan. 14, 2022 /PRNewswire/ -- Youngevity International, Inc. (OTC:YGYI), ("YGYI" or the "Company"), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTC:YGYIP) for each of January, February and March 2022.  The dividend will be payable on February 15, 2022, March 15, 2022, and April 15, 2022, to holders of record as of January 31, 2022, February 28, 2022, and March 31, 2022. The dividend will be paid in cash. About Youngevity International, Inc. Youngevity In

    1/14/22 12:57:00 PM ET
    $YGYI
    Catalog/Specialty Distribution
    Consumer Services